<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03548532</url>
  </required_header>
  <id_info>
    <org_study_id>2017/060</org_study_id>
    <nct_id>NCT03548532</nct_id>
  </id_info>
  <brief_title>Embryo Culture at a Constant Temperature of 36.6°C or 37.1°C</brief_title>
  <official_title>Embryo Culture at a Constant Temperature of 36.6°C or 37.1°C: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      On the day of oocyte retrieval, participants will be randomized to stable culture at 37.1°C
      or 36.6°C with the ultimate aim of finding a difference in clincial pregnancies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A previous study in our centre analysed stable embryo culture at 36.6°C and 37.1°C, on
      sibling oocytes. The primary aim was to analyse possible differneces in embryo development
      (utilization rate) up to day 5/6. In this study, the investigators found a high difference in
      clinical pregnancy rate between both groups (46.4% versus 77.4%). Since this study was not
      powered to find differences in clincial pregnancy rates between both groups, this RCT was
      especially powered as a superiority trial to find differences in clincial pregnancy rates
      between both groups. On the day of oocyte retrieval, patients will be allocated to culture at
      one of both temperatures.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Based on the randomisation list, patients fulfilling the inclusion criteria will be assigned to one of each arm. A total of 119 patients are needed in every arm in this superiority trial.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy</measure>
    <time_frame>7 weeks</time_frame>
    <description>ultrasound: sac and fetal heartbeat positive</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fertilization rate</measure>
    <time_frame>1 day</time_frame>
    <description>number of fertilized oocytes, per number of injected oocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>embryo development/utilization rate</measure>
    <time_frame>6 days</time_frame>
    <description>number of embryos transferred or cryopreserved per fertilized oocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>live birth rate of the fresh cycle</measure>
    <time_frame>43 weeks</time_frame>
    <description>number of live births per started cycle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cumulative live birth rate per cycle</measure>
    <time_frame>104 weeks</time_frame>
    <description>fresh and frozen embryo transfer: outcome of the deliveries</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">238</enrollment>
  <condition>Temperature; Extreme, Exposure</condition>
  <arm_group>
    <arm_group_label>36.6°C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Embryos of these patients will be cultured at 36.6°C from day 0 after ICSI, untill day 6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>37.1°C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Embryos of these patients will be cultured at 37.1°C from day 0 after ICSI, untill day 6.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>G210 incubator</intervention_name>
    <description>very stable culture temperature, up to 0.1°C, in both arms</description>
    <arm_group_label>36.6°C</arm_group_label>
    <arm_group_label>37.1°C</arm_group_label>
    <other_name>Ksystems</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Day 5 transfer

          -  Single embryo transfer

          -  Only ejaculated sperm (fresh or frozen, autologous or heterologous)

          -  BMI &lt;35

          -  Age &lt;40 years

          -  Cycle rank &lt;3 for the current child

          -  Last ultrasound: 8 follicles of at least 12 mm

          -  At least 6 mature oocytes

        Exclusion Criteria:

          -  IVF

          -  IVF versus ICSI

          -  Failed fertilization in previous cycle

          -  no previous cycle without embryo transfer

          -  No use of Ca ionophores for embryo quality or fertilization problems
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Greta Verheyen, PhD</last_name>
    <role>Study Director</role>
    <affiliation>UZBrussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neelke De Munck, PhD</last_name>
    <phone>024776694</phone>
    <phone_ext>0032</phone_ext>
    <email>neelke.demunck@uzbrussel.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Greta Verheyen, PhD</last_name>
    <phone>024774042</phone>
    <phone_ext>0032</phone_ext>
    <email>greta.verheyen@uzbrussel.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neelke De Munck, MSc.</last_name>
      <phone>024776694</phone>
      <phone_ext>0032</phone_ext>
      <email>neelkedemunck@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Neelke De Munck, MSc.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>October 23, 2017</study_first_submitted>
  <study_first_submitted_qc>June 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2018</study_first_posted>
  <last_update_submitted>September 22, 2018</last_update_submitted>
  <last_update_submitted_qc>September 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Neelke De Munck</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>temperature</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>For statistical Analysis</ipd_description>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>within 6 months after study completion</ipd_time_frame>
    <ipd_access_criteria>Only relevant information will be given to the statistician (who is also a clinical doctor in our centre)</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

